https://www.selleckchem.com/pr....oducts/Gefitinib.htm
Cells of prostate origin could be readily and specifically identified and separated into benign and malignant cell populations based on the multiplex test that consisted of markers specific for prostate cells (NKX3-1, PRAC1) and prostate cancer cells (PCA3). Upon evaluation of post-DRE urine from a pilot cohort of prostate cancer patients, we identified 11 samples in which prostate cells were present, 6 of which were also positive for prostate cancer cells. Multiplex RISH enables the direct visualization and molecular characterization
Me gusta
Comentario
Compartir
